Abstract
Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Current Bioinformatics
Title: Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression
Volume: 4 Issue: 3
Author(s): Wenguang Zhang, Jinquan Li, Rui Su and Wu Jianghong
Affiliation:
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Abstract: Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Export Options
About this article
Cite this article as:
Zhang Wenguang, Li Jinquan, Su Rui and Jianghong Wu, Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression, Current Bioinformatics 2009; 4 (3) . https://dx.doi.org/10.2174/157489309789071039
DOI https://dx.doi.org/10.2174/157489309789071039 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Innate Immunity and Vaccine Adjuvants: From Concepts to the Development of a Unique Adjuvant System AS04 Used for the Formulation of a Human Papillomavirus (HPV) Vaccine
Current Cancer Therapy Reviews Bioconjugation of Polymers: A Novel Platform for Targeted Drug Delivery
Current Pharmaceutical Design Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)
Current Cancer Drug Targets In Vitro Methods to Study the Interplay of Drug Metabolism and Efflux in the Intestine
Current Drug Metabolism Emerging Targets in Neurodegeneration: New Opportunities for Alzheimer's Disease Treatment?
Current Topics in Medicinal Chemistry Clinical Molecular Imaging with PET Agents Other than 18F-FDG
Current Pharmaceutical Biotechnology Chemoresistance in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting α-Secretase as an Alternative Drug Target for Treatment of Alzheimers Disease
Current Medicinal Chemistry Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals
Recent Patents on Anti-Cancer Drug Discovery Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by “ Molecular Tweezers” - from the Test Tube to Animal Models
Current Pharmaceutical Design Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa
Recent Patents on Nanomedicine Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Current Cancer Drug Targets Heat Shock Proteins as Prognostic Markers of Cancer
Current Cancer Drug Targets Drug Discovery and Protein Tyrosine Phosphatases
Current Medicinal Chemistry Giant Cell Arteritis – A Series of Cases and Review of Literature
Current Rheumatology Reviews Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer
Current Drug Targets Erbin, a Negative Regulator in Diverse Signal Pathways
Current Protein & Peptide Science Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization
Anti-Cancer Agents in Medicinal Chemistry